Clinical Trial Update: Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination [Phase 1]

View source ↗

Summary

Phase 1 trial comparing a fixed-dose capsule of esomeprazole 40 mg with LDA 325 mg to the free combination; the study was completed. Sponsored by AstraZeneca, i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease

Drugs mentioned

• Aspirin 325 mg (acetylsalicylic acid)
• Nexium (esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Ulcers, Upper GI Symptoms | Phase 1 | Status: COMPLETED